FLUORINATED PYRIMIDINES. XXIV. IN VIVO METABOLISM OF 5-TRIFLUOROMETHYLURACIL-2-C-14 AND 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE-2-C-14.

Suppr

超能文献

作者信息

HEIDELBERGER C, BOOHAR J, KAMPSCHROER B

出版信息

Cancer Res. 1965 Apr;25:377-81.

PMID:14281103

Abstract

摘要

相似文献

FLUORINATED PYRIMIDINES. XXIV. IN VIVO METABOLISM OF 5-TRIFLUOROMETHYLURACIL-2-C-14 AND 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE-2-C-14.

Cancer Res. 1965 Apr;25:377-81.

FLUORINATED PYRIMIDINES. XX. INHIBITION OF THE NUCLEOSIDE PHOSPHORYLASE CLEAVAGE OF 5-FLUORO-2'-DEOXYURIDINE BY 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.

Biochim Biophys Acta. 1963 Oct 15;76:315-8.

SYNTHESES OF 5-TRIFLUOROMETHYLURACIL AND 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.

J Med Chem. 1964 Jan;7:1-5. doi: 10.1021/jm00331a001.

FLUORINATED PYRIMIDINES. XIX. SOME BIOLOGICAL EFFECTS OF 5-TRIFLUOROMETHYLURACIL AND 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE ON ESCHERICHIA COLI AND BACTERIOPHAGE T4B.

J Mol Biol. 1963 Nov;7:541-60. doi: 10.1016/s0022-2836(63)80101-1.

FLUORINATED PYRIMIDINES. XXI. THE TUMOR-INHIBITORY ACTIVITY OF 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.

Cancer Res. 1964 Dec;24:1979-85.

THE EFFECT OF NATURAL AND UNNNATURAL PYRIMIDINES AND PYRIMIDINE NUCLEOSIDES ON THE PHOSPHOROLYSIS OF 5-IODODEOXYURIDINE BY MOUSE LIVER EXTRACT.

Biochem Pharmacol. 1964 Mar;13:365-70. doi: 10.1016/0006-2952(64)90153-4.

THE COMPARATIVE UPTAKE OF I-125-LABELED 5-IODO-2'-DEOXYURIDINE AND THYMIDINE-H3 INTO TISSUES OF MICE BEARING HEPATOMA-129.

Cancer Res. 1965 Feb;25:234-40.

Fluorinated pyrimidines. XXXII. Syntheses of 2',3'-dehydro-5-trifluoromethyl-2'-deoxyuridine and 5-trifluoromethyluridine.

J Med Chem. 1969 May;12(3):543-5. doi: 10.1021/jm00303a624.

STUDIES ON THE MECHANISM OF HUMAN TUMOR RESISTANCE TO THE FLUORINATED PYRIMIDINES.

Cancer Res. 1964 Sep;24:1437-47.

Determination of labile trifluoromethyl compounds with a fluoride--ion electrode: differential analysis of 5-trifluoromethyluracil and 5-trifluoromethyl-2'-deoxyuridine.

Anal Biochem. 1969 Oct 15;32(1):31-7. doi: 10.1016/0003-2697(69)90101-8.

引用本文的文献

Trifluridine/tipiracil as a therapeutic option in real life setting of metastatic colorectal cancer: An efficacy and safety analysis.

Front Pharmacol. 2022 Oct 13;13:1041927. doi: 10.3389/fphar.2022.1041927. eCollection 2022.

Emerging combination therapies for metastatic colorectal cancer - impact of trifluridine/tipiracil.

Cancer Manag Res. 2017 Oct 3;9:461-469. doi: 10.2147/CMAR.S113320. eCollection 2017.

The Role of Fluoropirimidines in Gastrointestinal Tumours: from the Bench to the Bed.

J Gastrointest Cancer. 2017 Jun;48(2):135-147. doi: 10.1007/s12029-017-9946-5.

Metabolism, Biochemical Actions, and Chemical Synthesis of Anticancer Nucleosides, Nucleotides, and Base Analogs.

Chem Rev. 2016 Dec 14;116(23):14379-14455. doi: 10.1021/acs.chemrev.6b00209. Epub 2016 Nov 23.

Effect of food on the pharmacokinetics of TAS-102 and its efficacy and safety in patients with advanced solid tumors.

Cancer Sci. 2016 May;107(5):659-65. doi: 10.1111/cas.12912. Epub 2016 Mar 28.

Human mass balance study of TAS-102 using (14)C analyzed by accelerator mass spectrometry.

Cancer Chemother Pharmacol. 2016 Mar;77(3):515-26. doi: 10.1007/s00280-016-2965-2. Epub 2016 Jan 19.

A novel antimetabolite: TAS-102 for metastatic colorectal cancer.

Expert Rev Clin Pharmacol. 2016;9(3):355-65. doi: 10.1586/17512433.2016.1133285. Epub 2016 Jan 22.

Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies.

Ther Adv Med Oncol. 2015 Nov;7(6):340-56. doi: 10.1177/1758834015603313.

TAS-102, a novel antitumor agent: a review of the mechanism of action.

Cancer Treat Rev. 2015 Nov;41(9):777-83. doi: 10.1016/j.ctrv.2015.06.001. Epub 2015 Jun 6.

Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.

Cancer Sci. 2007 Jun;98(6):779-89. doi: 10.1111/j.1349-7006.2007.00477.x. Epub 2007 Apr 18.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验